WallStreetZenWallStreetZen

NASDAQ: FNCH
Finch Therapeutics Group Inc Stock

$2.89+0.24 (+9.06%)
Updated Mar 27, 2024
FNCH Price
$2.89
Fair Value Price
-$0.00
Market Cap
$4.65M
52 Week Low
$2.19
52 Week High
$16.74
P/E
-0.06x
P/B
0.2x
P/S
54.14x
PEG
N/A
Dividend Yield
N/A
Revenue
$107.00k
Earnings
-$74.75M
Gross Margin
100%
Operating Margin
-74,565.42%
Profit Margin
-69,863.6%
Debt to Equity
1.42
Operating Cash Flow
-$32M
Beta
0.93
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

FNCH Overview

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered drugs in the U.S. The company collaborates and has license agreements with Takeda Pharmaceutical Company Ltd, Skysong Innovations LLC, and the University of Minnesota. The company was incorporated in 2014 and is based in Somerville, MA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how FNCH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

FNCH ($2.89) is overvalued by 79,177.77% relative to our estimate of its Fair Value price of -$0.00 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
FNCH ($2.89) is not significantly undervalued (79,177.77%) relative to our estimate of its Fair Value price of -$0.00 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
FNCH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more FNCH due diligence checks available for Premium users.

Be the first to know about important FNCH news, forecast changes, insider trades & much more!

FNCH News

Valuation

FNCH fair value

Fair Value of FNCH stock based on Discounted Cash Flow (DCF)
Price
$2.89
Fair Value
-$0.00
Undervalued by
79,068.47%
FNCH ($2.89) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
FNCH ($2.89) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
FNCH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

FNCH price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.06x
Industry
14.3x
Market
44.45x

FNCH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.2x
Industry
6.2x
FNCH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

FNCH's financial health

Profit margin

Revenue
$0.0
Net Income
-$3.0M
Profit Margin
0%
FNCH's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
FNCH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$55.4M
Liabilities
$32.5M
Debt to equity
1.42
FNCH's short-term assets ($25.85M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FNCH's long-term liabilities ($28.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FNCH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.7M
Investing
$51.0k
Financing
$0.0
FNCH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

FNCH vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
FNCH$4.65M+9.41%-0.06x0.20x
ARTL$4.74M+2.08%-0.47x0.40x
LIPO$4.50M-3.87%-0.94x1.43x
VRPX$4.42M-2.84%-0.29x2.28x
SCPX$4.28M-6.29%-0.08x0.12x

Finch Therapeutics Group Stock FAQ

What is Finch Therapeutics Group's quote symbol?

(NASDAQ: FNCH) Finch Therapeutics Group trades on the NASDAQ under the ticker symbol FNCH. Finch Therapeutics Group stock quotes can also be displayed as NASDAQ: FNCH.

If you're new to stock investing, here's how to buy Finch Therapeutics Group stock.

What is the 52 week high and low for Finch Therapeutics Group (NASDAQ: FNCH)?

(NASDAQ: FNCH) Finch Therapeutics Group's 52-week high was $16.74, and its 52-week low was $2.19. It is currently -82.71% from its 52-week high and 32.15% from its 52-week low.

How much is Finch Therapeutics Group stock worth today?

(NASDAQ: FNCH) Finch Therapeutics Group currently has 1,605,763 outstanding shares. With Finch Therapeutics Group stock trading at $2.89 per share, the total value of Finch Therapeutics Group stock (market capitalization) is $4.65M.

Finch Therapeutics Group stock was originally listed at a price of $639.61 in Mar 19, 2021. If you had invested in Finch Therapeutics Group stock at $639.61, your return over the last 3 years would have been -99.55%, for an annualized return of -83.46% (not including any dividends or dividend reinvestments).

How much is Finch Therapeutics Group's stock price per share?

(NASDAQ: FNCH) Finch Therapeutics Group stock price per share is $2.89 today (as of Mar 27, 2024).

What is Finch Therapeutics Group's Market Cap?

(NASDAQ: FNCH) Finch Therapeutics Group's market cap is $4.65M, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Finch Therapeutics Group's market cap is calculated by multiplying FNCH's current stock price of $2.89 by FNCH's total outstanding shares of 1,605,763.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.